Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 21, 2026.

Composites of Polymer Hydrogels and Nanoparticulate Systems for Biomedical and Pharmaceutical Applications

Fuli Zhao, Dan Yao, Ruiwei Guo and 3 more

Nanomaterials · 2015 · Review · CC BY

doi:10.3390/nano5042054

Abstract

Due to their unique structures and properties, three-dimensional hydrogels and nanostructured particles have been widely studied and shown a very high potential for medical, therapeutic and diagnostic applications. However, hydrogels and nanoparticulate systems have respective disadvantages that limit their widespread applications. Recently, the incorporation of nanostructured fillers into hydrogels has been developed as an innovative means for the creation of novel materials with diverse functionality in order to meet new challenges. In this review, the fundamentals of hydrogels and nanoparticles (NPs) were briefly discussed, and then we comprehensively summarized recent advances in the design, synthesis, functionalization and application of nanocomposite hydrogels with enhanced mechanical, biological and physicochemical properties. Moreover, the current challenges and future opportunities for the use of these promising materials in the biomedical sector, especially the nanocomposite hydrogels produced from hydrogels and polymeric NPs, are discussed.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 21, 2026. Paragraph numbers are ours, so an answer can point at one.

1. Hydrogels and Their Biomedical and Pharmaceutical Applications

Due to the remarkable characteristics, such as flexibility and versatility in fabrication, variety in composition, high tunability in the physical, chemical, and biological properties, high moldability in shape, especially their excellent biocompatibility and similarity to native extracellular matrix (ECM), hydrogels as promising materials are of greatest significance in the biomedical fields and have been most extensively studied in academic and industrial research. Hydrogels are a class of materials that present a three-dimensional (3D) network formed from hydrophilic homopolymers or copolymers crosslinked to form insoluble polymer matrices, which are able to absorb a large amount of water or biological fluids. Moreover, some “intelligent” hydrogels could undergo reversible and significant changes in structure, shape, and/or property after being exposed to external physical/chemical/mechanical stimuli, such as pH value, temperature, ionic strength, enzymatic activity, glucose concentration, light, electric field, magnetic field, pressure and solvent composition or a combination of them. Therefore, these stimuli-sensitive are expected to contribute significantly to the exploration and development of next generation of biomaterials for biological and biomedical applications, such as self-regulated and site-specific drug delivery systems, specialized separation systems or bioreactors.

Since Wichterle and Lim first reported a hydrogel for contact lens application in 1960 based on crosslinked poly-2-hydroxy-ethylmethacrylate (PHEMA) hydrogel by use of ethylene glycol dimethacrylate (EGDMA), significant progress has been achieved and a diverse range of polymers have been used for the synthesis and fabrication of hydrogels for various applications. Besides the PHEMA, a great number of synthetic polymers were explored for preparation of hydrogels by polymerization or cross-linking, such as poly(ethylene glycol) (PEG), poly(vinyl alcohol) (PVA), polyacrylic acid (PAA), poly(2-hydroxypropyl methacrylamide) (PHPMA), polyvinyl pyrrolidone (PVP), polyurethanes (PU), polyacrylamide (PAM), poly(dimethylaminoethyl methacrylate) (PDMAEMA) and poly(N-isopropyl acrylamide) (PNIPAM) as well as polypeptides and polyesters. The polymeric hydrogels from synthetic sources are advantageous, because they usually possess controllable chemical structure and architecture, degradation rates, and mechanical strengths. However, most of them lack biological cues for biological applications, especially for proliferation of cells and tissue regeneration. Natural hydrogels derived from natural sources, such as chitosan (CS), hyaluronic acid (HA), gelatin (GEL), collagen (COL), alginate (ALG), elastin (ELA), heparin (HEP) and chondroitin sulfate (CRS), are appealing for biological and biomedical applications because of their cell-interactive properties, cell adhesion and cell signaling, as well as biodegradability and excellent biocompatibility. However, their uses are often restricted due to uncontrollable degradation and structure, low mechanical properties, potential immunogenicity and high batch-to-batch variations. The well designed and tailored hydrogel materials can be obtained by the combination of natural and synthetic polymers, which have resulted in a shift towards the use of hydrogels based on semisynthetic polymers for biological and biomedical applications, such as P(PEG-co-peptides), ALG-g-(PEG-PPO-PEG), P(PLGA-co-serine), COL-acrylate, P(HPMA-g-peptide) and HA-g-PNIPAM.

Briefly, a hydrogel is a crosslinked hydrophilic polymeric network with high amount of water, and thus any techniques which are able to crosslink polymer chains can be applied to prepare a hydrogel. Gelation can take place either by chemical crosslinking (chemical gelation involving formation of permanent covalent bonds) or by physical crosslinking (physical gelation through the emergence of reversible and transient junctions). Chemically crosslinked hydrogels are commonly prepared by radical polymerization of a hydrophilic monomer in the presence of a multifunctional cross-linking agent, or condensation polymerization of monomers with multifunctionalities. Chemical gelation can also occur through covalent bonding between polymeric chains through energy irradiation, chemical reactions or sulphur vulcanization by the addition of different chemicals (crosslinker). The 3D integrity of hydrogels in the swollen state can also be retained by physical crosslinking through molecular entanglements and/or secondary forces, such as hydrogen bonding, ionic or hydrophobic interactions. Recently, the emergence of bio-orthogonal and supramolecular chemistries provides great opportunities for scientists to create multifunctional physically cross-linked hydrogel matrices. All of these interactions are reversible, and thus they can be disrupted by changing physical conditions (pH, temperature, and ionic interactions), as shown in Figure 1. Generally speaking, chemically crosslinked gels often have much higher mechanical properties than their physically crosslinked counterparts. However, the residual organic solvents, chemical crosslinkers, and/or unreacted monomers could leach out from the hydrogels continuously and cause cytotoxicity.

Hydrogels have a variety of properties, such as absorption capacity, swelling behavior, stability and degradation, bioadhesion and bioactivity, permeability, mechanical properties optical and surface properties, which make them promising materials for diverse applications. In theory, most of features can be engineered into a hydrogel system. Biodegradability of hydrogels is essential for biomedical applications that require controlled resorption in vivo or local dissolution to favor cell activities and facilitate tissues reparation. Most of hydrogels are able to undergo local or bulk dissolution by hydrolysis, proteolysis or disentanglement. One of the most remarkable characteristics of hydrogels is their highly porous structure, allow for a depot maintaining a high local concentration of drug at the targeted tissues. Therefore, the transportation capability of hydrophobic/hydrophilic molecules is very important for a hydrogel-based drug delivery system. The drug diffusion and release behavior through the polymer network can easily be regulated by manipulating the crosslinking density in the gel matrix and thus controlling the porosity (mesh size) of hydrogels. For their use as scaffolds for tissue regeneration or as tissue adhesives in surgical reparation, the bioadhesion ability of hydrogels is also a significant property that allows tissues and cells to adhere to hydrogels. The hydrogels can be modified by using linker molecules that enable non-covalent or covalent molecular interactions between the gel matrix and its surroundings to improve the cell/tissue-adhesive properties. The design of hydrogels with a good mechanical performance is of crucial importance in many biomedical application areas. In addition, the water content of a swollen hydrogel plays a key role in the biomedical applications of hydrogels, as it can significantly influence the solute diffusion and mechanical properties of the hydrogels. In sum, the suitability and performance of hydrogels as unique materials in a biomedical application largely depend on their network architecture. The network structure of hydrogels can be characterized mainly by analyzing the polymer volume fraction in the swollen state, detecting the polymer chain length between two adjacent crosslinking points and calculating the corresponding mesh size. The molecular structure of hydrogels can also be tuned by the selection of polymer, crosslinker and type of crosslinking as well as by the control of the crosslinking density, which offer great versatility in preparing hydrogels with tailorable network and mechanical strengths.

As mentioned above, due to the aforementioned remarkable properties, hydrogels as promising materials are highly suitable for different applications, especially for diagnostic and therapeutic applications in biomedical areas. They not only can serve as a vehicle to load and deliver drug or protein to tissues, but also can act as scaffolding materials to fabricate artificial tissues and organs for transplantation and serve as wound dressings, barriers or adhesives between material and tissue surfaces. In addition, they are able to be applied to mimic the natural extracellular matrix (ECM) and thus offer support for cell migration, proliferation and adhesion, which can offer not only a solution for large-scale cell manufacturing and protein production, but also a platform for stem cell research and cell therapy. Moreover, hydrogels can be cast into practically any shape, size, or form. And especially the stimuli-responsive hydrogels can respond to their surrounding environments, which have opened a new avenue for biomedical research in numerous leading edge applications, such as medical and biological sensors and actuators, diagnostic imaging and devices.

Overall, hydrogels have become a popular choice of materials for biomedical and pharmaceutical applications. However, despite the many favorable characteristics of hydrogels, problems still exist in many aspects, limiting their broad clinical applications. For example, for the hydrogel-based drug delivery system, the homogeneity and quantity of drug loading into hydrogels is often very difficult, particularly in the case of hydrophobic drugs. The large pore sizes and high water content of most hydrogels often lead to relatively rapid drug release. The premature drug release outside the targeted site not only decreases the therapeutic efficacy, but also causes serious local or systemic toxicity. Besides, some hydrophobic drug crystal precipitation tends to occur in the hydrogels, generally causing poor formulation stability and a low drug-loading capacity. Hydrogels are generally prepared from a single polymer network, which often does not hold all the required mechanical and biological properties for tissue engineering applications. They commonly tend to be too flexible to meet the mechanical demands of certain applications, leading to premature dissolution or flow away of the hydrogels from a targeted local site. Moreover, the current hydrogels used in tissue engineering applications are still unable to replicate the complexities of the native environment, and thus often leading to unsatisfactory results. There is an increasing need for functional hydrogels to be used as biosensors, actuators and biologic devices, which are generally based on the measurement of hydrogels’ changes in response to magnetic, optical and/or electrical stimuli. However, most of hydrogels made from polymers are completely inert and non-responsive under the magnetic and electrical conditions. Apparently, each of these issues significantly restricts the practical use of hydrogels in the clinic. As a result, it is imperative to develop new materials and novel strategies for the introduction of physicochemical, mechanical, and biological functionality into hydrogels to meet the rigorous and diverse demands.

One of the efficient and simple approaches to improve the hydrogels properties and to include multiple functionalities is the incorporation of different entities into hydrogels to fabricate composite hydrogel matrices. For example, the strategy of introducing the secondary polymers into hydrogels by physical blending or copolymerization to form hybrid hydrogels or interpenetrating network structure (IPN) hydrogels. A variety of nanoparticles (NPs) have distinct physicochemical properties and favorable functions that are not commonly found in polymers. Recently, considerable efforts have been made to incorporate various kinds of NPs into gel matrices to create novel nanocomposite hydrogels with superior properties and tailored functionalities. This review will summarize the most recent developments in the domain of nanocomposite hydrogels in biomedical and pharmaceutical applications, specifically highlighting some interesting discoveries in composites of hydrogel and polymeric NPs for biomedical applications.

2. Nanoparticles and Their Biomedical and Pharmaceutical Applications

Parallel to the aforementioned developments in hydrogels, nanoparticulate systems have gained a great amount of attention in the past several decades as one of the most promising biomedical materials, due to their unique physicochemical properties, nano-sized characteristics, controlled shape and versatile modification possibilities as well as well-defined multifunctionalities. Significant progress has been achieved in preparation and functionalization of various nanoparticles for a diverse array of biomedical applications. Researchers have developed and employed a wide variety of nanomaterials, such as carbon-based NPs (e.g., carbon nanotube, graphene, fullerene), silica-based NPs, and other inorganic NPs, semiconductors NPs, metal and metal oxide NPs (e.g., Au, Ag and iron oxides), as well as liposomes, and polymer-based NPs (e.g., polymeric NPs, micelles and nanogels, polymersomes, dendrimer, polymer-drug conjugations, emulsion particles and protein NPs). As shown in Figure 2, these nanomaterials provide a powerful platform for site-specific and controllable delivery of drugs, gene, proteins and other bioactive agents; some of them exhibited noticeable antibacterial, antiviral and antifungal activities. Some other inorganic nanoparticles, such as gold NPs, semiconductor NPs and magnetic NPs, can be used for photoacoustic, photothermal or photodynamic as well as hyperthermal therapy, due to their unique physical properties. In addition, some functional NPs can find applications for a new generation of intelligent biosensing, bioseparation, bioimaging, cell labeling and diagnosing as well as monitoring of cells and tissues.

NPs enter the human body by injection, inhalation, ingestion or through the skin. Once invading a biological milieu, NPs will inevitably contact with a huge variety of biomolecules in body fluids or blood, such as sugars, proteins, and lipids, which could immediately coat the NP surfaces leading to the formation of the so-called “protein corona”. If the NPs can avoid the clearance by the reticuloendothelial system (RES) and/or mononuclear phagocytic system (MPS) and remain in circulation, they will reach the target tissues or cells and finally be internalized by targeted cells. Undoubtedly, NPs’ transport behavior in blood, uptake and clearance by macrophages, consequent biodistribution and metabolism, as well as their internalization by targeted cells are critical for their therapeutic and diagnostic applications and are dictated by the physicochemical properties of NPs, such as hydrophilic–lipophilic property, surface feature and particle size, particle shape.

Generally, the biological use of NPs requires hydrophilicity for good dispersion in water or serum to impede aggregation and opsonization, and thus NPs are usually coated with hydrophilic polymers, surfactants, and biodegradable copolymers, e.g., PEG. However, hydrophobicity is also required to promote the interaction of NPs with the cellular membrane to improve uptake into cells. As a result, the anchoring of the hydrophilic ligands to the NPs surface can prolong the circulation time of NPs, but they also can dramatically suppress the interactions between NPs and cells, thus leading to a minimal internalization. It was also worth pointing out that both corona formations between NPs with proteins in body fluids and interactions between NPs-bound ligands with cell membranes are influenced by the ligand type, ligand structure and ligand packing density on the surface of NPs.

Surface charge is another important factor that can definitely affect the fate of NPs administered in biological systems. Because the cell membranes have a slight negative charge and cellular uptakes are driven by electrostatic attractions, positively charged NPs, compared with NPs with a neutral or negative charge, have higher affinity with negatively charged cell membranes, leading to a faster and more efficient cellular uptake. However, positive NPs always have serious aggregation and rapid clearance after injection due to the nonspecific interactions with blood components.

In addition of surface properties of NPs, nanomaterial size and shape also contribute significantly to their biodistribution in circulation and the clearance from the body, as well as interaction with subcellular organelles, cells, tissues, and organisms. NPs, are often defined as solid particles with a size in the range of 10–1000 nm. However, the size of NPs suitable for systemic administration for therapeutic applications might be in the range between 2 and 200 nm. Firstly, the size of NPs can affect their permeability out of the vasculature, the clearance from the body and biodistribution in vivo. Some previous studies have indicated that the smaller the size of NPs will lead to the less the interactions with endothelial cells and the higher the concentration in a blood vessel, as well as the longer the blood circulation time. NPs with size of less than 20 nm showed wide spread in various organs by crossing the tight endothelial junctions. They were found in almost all organs, including the blood, heart, lungs liver, kidneys, spleen, testes, thymus, and brain. In general, small particles are less likely to be taken up by macrophages than large ones. However, NPs with size of less than 20 nm are rapidly excreted through the glomeruli of kidney. Large NPs tended to aggregate under physiological conditions and be retained mechanically by capillaries, which were mainly detected only in the blood, liver and spleen. Generally, the ideal size of NPs for long circulation should be in the range of 20–200 nm. The size of NPs should be larger than 20 nm in diameter in order to avoid filtration by the kidney and smaller than 200 nm to avoid specific sequestration by fenestra of liver and sinusoids in spleen. In the case of accumulation of NPs in tumor tissues, the pores or fenestrations in tumor tissues are much larger (>100 nm) than the tight endothelial junctions of normal vessels (<10 nm), allowing NPs to passively accumulate inside the tumor (termed enhanced permeation and retention (EPR) effect) after extravasation. Researches have demonstrated that the capacity of NPs to navigate between the tumor interstitium decreased with increasing size. Large NPs are very difficult to extravasate far beyond the blood vessel, whereas small NPs easily enter the tumor parenchyme through tumor vasculatures, but they remain there only transiently due to the rapid secretion from the tumor. The size of NPs is also one of the major factors determining the efficiency and mechanism of cellular uptake. NPs are internalized into the cell through various pathways, such as pinocytosis and phagocytosis. Large particles are most likely to be engulfed by macropinocytosis. Internalization of NPs with a diameter of less than 200 nm involved a clathrin-mediated endocytosis process. With size increasing, the caveolae-mediated internalization becomes more predominant. The shape of NPs also plays a very important role in their in vivo behavior and interaction with cells. Some studies suggested that spherical NPs of similar size were uptaken significantly more efficiently than non-spherical NPs, due to greater membrane wrapping time required for the elongated NPs. However, non-spherical NPs exhibit superior properties to their spherical counterparts in terms of escaping from phagocytosis, circulating in blood and binding to the target tissues. In sum, prior to the widespread applications of NPs in biomedical and pharmaceutical field, it should be very important to demonstrate how the physicochemical properties of NPs interact with subcellular organelles, cells, tissues, and organisms. And the effect of physicochemical properties of NPs on biological systems should be fully taken into consideration toward the development of the next generation of therapeutic and diagnostic NPs.

Despite the many advantages making NPs a great candidate for various biomedical applications, there remains a lot of pressing challenges for us to face in the future. In certain applications such as the development of drug delivering systems, for example, “Soft” drug carriers (including liposomes, micelles, dendrimers and polymeric NPs) often suffer from the premature release of drugs under harsh environmental conditions and incontrollable drug release rate in vivo. These bioorganic NPs, such as liposomes and polymeric micelles, are generally formed by spontaneous aggregations, which are dynamically unstable system owing to the weak nature of the cohesive interactions. They often displayed low resistance to dilution-induced disassembly in vivo and high instability during storage as well as relatively small loading capacity. Compared to the above soft organic NPs, “Hard” nanomaterials (e.g., NPs originated from carbon, silica, metal and metal oxides, quantum dots (QDots), et al.) have many fundamental advantages. These various inorganic NPs possess plenty of intrinsic functionalities, because of the optical, magnetic, electrical and physical properties. They could be made into integrated and multifunctional systems, including stimuli-responsive release, specific tissue/cell type targeting, in vivo imaging for diagnosis, photothermal treatment, and drug delivery monitoring, which are normally unable to be found in the above “Soft” nanomaterials. Besides, “Hard” inorganic NPs are generally consisted of a three-dimensional arrangement with linked atoms mainly via covalent or metallic bonds. And therefore these particles are highly ordered and extremely stable in circulation and during storage. However, compared with the polymeric NPs, these inorganic NPs often suffer from a very low biocompatibility and a very high foreign body response or inflammatory response. In fact, as for the biomedical applications of most of nanomaterials, the toxicity toward normal tissues or non-targeted cells is the most formidable obstacle to be overcome. In addition, to exert its pharmacological effects, NPs administrated must be remained in the circulation long enough and reach the required concentration. Therefore, another main challenge toward designing NPs for biomedical applications is how to avoid rapid clearance from circulation by MPS or RES after administration. It was well known that, once entering blood circulation, NPs will be rapidly coated with serum proteins and then cleared through renal systems or sequestered in the liver or spleen. In order to enhance the biocompatibility and evade the opsonization process, various biomolecules and ligands were anchored by physical adsorption or chemisorption on the surface of NPs, especially for inorganic NPs. The functionalized NPs displayed higher colloidal stability, improved biocompatibility as well as anti-opsonization activity under physiological conditions. However, the physicochemical characteristics of the particle can drastically change with even the slightest changes in the morphology and surface of NPs arising from functionalization process, significantly impairing their functionality and performance the high cost. Moreover, the complicated synthesis steps and low stability as well as harsh reaction condition and tedious purification process limit their large-scale production. Therefore, there is still an urgent need to develop a couple of simple and efficient strategies to functionalize NPs in order to foster the successful applications of NPs for diagnostic and therapeutic purposes.

3.1. Nanocomposite Hydrogels: A Brief Overview

As mentioned above, because of their unique structures and properties, the three-dimensional hydrogels and NPs have shown a very high potential for medical therapeutic and diagnostic applications. However, some inherent limitations of hydrogels and NPs inhibited their widespread applications. For example, with the rapid development of biomedicine, there is an increasing demand for multifunctional hydrogel with enhanced mechanical property. However, the limited functionalities and inferior mechanical properties of hydrogels have hindered their wide applications. As for NPs, they have plenty of unique multifunctionalities for biomedical applications, but the high instability, low biocompatibility and opsonization activity still remain significant clinical challenges. To meet increasingly rigorous requirements for biomedical use, various strategies have been explored to surmount the drawbacks but meanwhile maintain the advantages of hydrogels and NPs. Among them, the design and fabrication of novel biomaterials with desirable functions and excellent performances by innovative combination of these two entirely different types of materials has gained enormous attention.

Composite materials are materials which consisted of two or more constituent materials with significantly different physicochemical properties. When two or more components are combined in a single entity where the individual components remain distinct and separate, the resultant composite materials can exhibit markedly different characteristics from the individual components. Originally, the advantages of fabrication of composite materials by incorporating a second component into the main matrix are usually for the purpose of strength enhancement and reinforcement. For example, mud and straw were combined to form bricks several thousand years ago. Concretes are actually a composite of stones in a matrix of cement, which have been widely used for buildings. Recently, to address the specific biological and clinical challenges, the incorporation of nanostructured fillers into hydrogels has been developed as a popular means for the creation of novel materials with diverse functionality. The resulting nanocomposite hydrogels, also known as hybrid hydrogels, can be defined as composite material that physically or covalently incorporates nanosized particles or nanostructures into a matrix of cross-linked polymer networks. These nanocomposite hydrogels have found fascinating interest for various biomedical applications due to combining the characteristics of a nanoparticulate material (e.g., very small size and high surface area) with hydrogel system (e.g., hydrophilicity and extremely high water content). As shown in Figure 3, the rigid NPs and flexible polymers can be looked as bricks and mortar. The polymer mortar connects the bricks to maintain the structural integrity and offer stability to the NPs; meanwhile NPs bricks render new functionalities to the composites. As a result, the challenges in the application of hydrogels and NPs, as mentioned above, could potentially be overcome by the fabrication of nanocomposite hydrogels. For example, the main aim of incorporation of NPs into hydrogel networks in the early attempts was to improve mechanical properties of hydrogel. Usuki et al. significantly improved the tensile strength of hydrogels by incorporating montmorillonite, a type of natural silicate mineral (“clay”) NPs, into nylon-6 network. The inorganic clay NPs are also rendered hydrophilicity and solubility when they are dispersed into 3D polymer networks, which can meet the essential requirements for the reasonable wound dressing with some desirable characteristics. In recent reports, nanocomposite hydrogels prepared by incorporation of silica NPs with hydrogels showed remarkable improvements in mechanical stiffness, tissue stickiness and bioactivity compared with unmodified hydrogels. In addition, the incorporation of metal NPs into hydrogel networks will impart superior physicochemical properties absent in the individual components. For example, incorporation of gold or silver NPs into a polymer matrix will render excellent antimicrobial property. Similarly, the entrapment of magnetic NPs into polymer networks can make hydrogels exhibit magnetic character. Meanwhile, the NPs embedded in hydrogel matrix are endowed with particular surface properties, which can avoid aggregation and sedimentation. In sum, the innovative combinations of hydrogels and NPs generate not only structural diversity but also a plurality of property enhancements.

Apparently, the fabrication of composite materials of hydrogels and NPs provides an efficient route to improve their performances and expand their application scopes. A range of NPs such as carbon-based nanomaterials (carbon nanotubes (CNTs), graphene, fullerene), inorganic/ceramic NPs (silica, silicates, clay, hydroxyapatite, calcium phosphate, quantum dots (QDots)), metal/metal-oxide nanoparticles (gold, silver, copper, platinum, iron oxides and titanium oxides) and organic NPs (polymer NPs, micelles, polymersomes, dendrimers and liposomes), have been integrated within the hydrogel networks to obtain nanocomposite hydrogels with tailored functionality and superior physicochemical and biological properties. As the definition suggested, nanocomposite hydrogels can be made through the combination of NPs and hydrogels via various mechanisms. Recently, Thoniyot et al. summarized the main approaches to prepare nanoparticle-hydrogel composites. The simplest method to prepare a nanocomposite hydrogel is the gelation of a suspension of pre-ready NPs in a solution of hydrogel-forming monomer. For example, Sershen et al. report a gold (Au) NPs- acrylamide hydrogel composites can be prepared by adding pre-formed Au NPs into a solution of acrylamide monomers and then initiating the polymerization by addition of the gelation initiator. This approach has been widely used to prepare a variety of nanocomposite hydrogels containing various NPs. However, some drawbacks limit its wide applications, such as the aggregation of NPs in monomer solution before and during the gelation process, and the leaching of NPs out of the hydrogel matrix if the cross link density is low. Another common approach to obtain nanocomposite hydrogels is to physically introduce NPs into a hydrogel networks after gelation. Some hydrogels, such as PAM hydrogel can highly swell in water but dramatically shrink in an aprotic solvent acetone. NPs can be introduced into this kind of hydrogels in the repeated swelling-shrinking process. Typically, the suspended NPs in water will be embedded in the swelling hydrogel when the shrunken gel in acetone was placed in an aqueous solution of NPs. After washing out the weakly surface-adsorbed NPs, the nanocomposite hydrogel was obtained. The NPs can be introduced into hydrogel matrix and remain attached within the gel, possibly owing to the physical entanglement and/or hydrogen bonding interactions between the polymer chains and NPs surface. Alternatively, the incorporation of NPs into pre-formed gels could also be achieved by repeated heating, centrifugation and redispersion according to similar mechanism. The NPs can also be created in situ after gelation of the hydrogel and subsequent conversion of the nanoparticle precursors suspended in the gel. In fact, the porous structures of hydrogel networks are very suitable for in situ formation of NPs, as the free space among the gel network provided a nanoscopic pot for formation and growth of NPs without aggregations. Apparently, this method involves loading NPs precursors into the hydrogel networks, rather than preformed NPs. In a typical procedure, Au (III) or Ag (I) ions were embedded PNIPAM or PAA hydrogel networks and then the Au or Ag ions functionalized polymer hydrogels were reduced or hydrolyzed to yield metal NPs-hydrogel composites. One particularly innovative approach to yield NPs-hydrogel composites is the use of crosslinker groups on the outer surface of NPs to form the hydrogel matrix. This concept was well demonstrated by Rose et al. for adhesion between two hydrogels. A rapid and strong adhesion between two hydrogels can be achieved by adding a droplet at room temperature of silica NPs solution on the surface of the hydrogels, as shown in Figure 4. This method was dependent on the ability of NPs to act as a connector between polymer chains or to be adsorbed onto the polymer gels. Finally, the nanocomposite material can also be obtained by using the interactions among NPs, polymers, and distinct gelator molecules to form positively charged polymers into NPs-hydrogels composites. These strategies for the fabrication of nanocomposite hydrogels bearing tailored functionality have opened up new possibilities in fabricating advanced biomaterials for various biotechnological and biomedical and applications. Different types of NPs-hydrogel composites and their associated properties and applications will be described below.

3.2. Nanocomposite Hydrogels from Hydrogels and Carbon-based NPs

Hydrogels, generally prepared from a single or multiply polymer networks, often lack all the required mechanical properties for tissue engineering applications. And they are also short of functions (such as electrical, optical and thermal conductivity) for the applications of controlled drug delivery or biosensing and bioimaging. Therefore, some strategies have been employed to improve the properties of hydrogels, mainly by inclusion different entities into hydrogel matrices to create composite hydrogels. In the past two decades, carbon-based NPs, such as carbon nanotubes (CNTs), graphene and fullerene (C60) have gained worldwide popularity, due to their excellent multifunctional feature and unique physicochemical properties (i.e., mechanical strength, corrosion resistance, low cost and friendly to the environment, especially thermal, electrical, and optical conductivity). As a result, extensive research efforts are reported to utilize the favorable and unique properties of carbon-based NPs to create composite materials for various applications, including sensors and actuators, photothermal and photodynamic therapy, diagnostic imaging and drug delivery devices. For example, due to their remarkable mechanical properties, carbon-based NPs have been widely used to incorporate into hydrogels to improve their physical and mechanical properties for a variety of tissue applications. A great number of studies have demonstrated that a small amount of carbon-based NPs, such as CNTs or graphene, in the polymer matrix can markedly change its mechanical, electrical and thermal properties. However, the key problem of the practical use of CNTs is their poor dispersibility in water, organic solvents and polymer matrix. Generally, some pretreatments, such as functionalization with strong acid or surface modification with surfactants, polymers or proteins, are needed to improve the dispersion of CNTs. Among various carbon-based NPs, graphene-based materials (including graphene, graphene oxide (GO) and reduced graphene oxide (rGO)) have been extensively explored as a novel reinforcing agent to support polymers for biomedical applications, due to their distinctive properties, such as large surface area (2620 m2/g), high aspect ratio, outstanding mechanical properties (Young’s modulus of 1 TPa and intrinsic strength of 130 GPa), excellent thermal and electrical conductivity as well as good optical transparency. However, graphene is neither lipophilic nor hydrophilic, often causing a high difficulty in their processing and low compatibility with polymer matrices. In contrast, GO, a single monomolecular layer of graphite with various oxygen containing groups such as epoxide, carbonyl, carboxyl and hydroxyl groups, is amphiphilic and thus can be dispersed in water and alcohol through hydrogen bonding. This will significantly facilitate molecular dispersion of GO in polymeric matrix and simplify the processing of GO-based composites. As a result, GO as a reinforcement agent can be directly introduced to into polymer matrices by solvent blending method. Nevertheless, as shown in Figure 5, the stable inclusion of graphene in a polymer matrix often requires pretreating graphene (such as surface and structural modifications) or post-treating hybrid hydrogel (such as crosslinking). Undoubtedly, the incorporation of graphene-based materials into hydrogel has proved extremely valuable for the improvement of the mechanical and thermal properties of the hydrogels. However, it was worth pointing out that the embedment of graphene-based materials into a hydrogel matrix is often indispensable, especially when these graphene-based materials were used in biomedical and biological fields. Normally, the graphene sheets have sharp edges, which can assist penetration through cell membranes. However, the sharp edges will also markedly enhance the cytotoxicity. The confinement of graphene in a water-rich environment of hydrogels can change its interaction with cells and thus offer a solution to prevent this effect.

In addition, hydrogels commonly made from non-conductive polymers are not conductive towards optical, thermal and electrical stimuli. However, there is an increasing need for conductive hydrogels in the biomedical applications, such as biosensors, actuators and neural tissue engineering. Therefore, carbon-based NPs with excellent optical, thermal and electrical conductivity are considered as highly promising materials to engineer conductive stimuli-responsive hydrogels. A variety of optical or electrical-responsive nanocomposite hydrogels as actuator, biosensor or tissue engineering scaffold have been developed by incorporating with carbon-based NPs. Overall, due to the fact that the carbon-based NPs often possess highly desirable functions that cannot be commonly found in polymers, the strategies of integrating carbon-based NPs into polymer hydrogels to develop composite hydrogels with enhanced mechanical strength and specialized properties (e.g., electrical, thermal and optical conductivity) are expected to be extensively explored for biomedical applications. And these and related topics have been well covered in several excellent reviews. And therefore, as shown in Table 1, we just summarized the latest advances of experimental research on nanocomposite hydrogels from hydrogels and carbon-based NPs for biomedical and pharmaceutical applicants.

3.3. Nanocomposite Hydrogels from Hydrogels and Inorganic NPs or Semiconductor NPs

In addition of carbon-based nanomaterials, some other inorganic NPs, such as silicon-based NPs and quantum dots (QDots) have been widely used to combine with the polymeric network to create composite materials with unique properties and functions. Especially, silicon-based NPs, including silica NPs (SiO2), mesoporous silica NPs (MSNs), hydroxyapatite (HAP) and bioactive glasses as well as various kinds of clay (such as montmorillonite (MMT), laponite (LAP), attapulgite and halloysite) are of greatest significance and have been utilized as the nanofillers in nanocomposite hydrogels, largely due to their excellent biocompatibility, chemical inertia, high thermal and mechanical stability, facile surface modification and easy functionalization. Most of these silicon-based NPs or nanoclays are already present in the body or are necessary for the normal functioning of human tissues. Silicon is very important in skeletal development. Silicon promotes collagen type I synthesis and also stimulates the osteogenic differentiation in human stem cells. HAP is a major mineral component and an essential ingredient of normal bone and teeth and HAP used biomaterials for bone regeneration can promote new bone ingrowth through osteoconduction mechanism without causing any local or systemic toxicity, inflammation or foreign body response. Some studies demonstrated that some nanoclays, such as MMT and LAP, can induce osteogenic differentiation of human mesenchymal stem cells in the absence of exogenous growth factors. It was well-known that many of the currently available polymer hydrogels suffer from poor mechanical properties and inability to induce mineralization. These unique bioactive properties and high mechanical strength of the silicon-based NPs and nanoclays will be of great interest to develop nanocomposite hydrogels with excellent mechanical and biological properties for the repair and regeneration of human tissues and body functions. Especially, the anisotropic and plate-like, high aspect-ratio morphology of the nanoclays, lead to the formation of high non-covalent surface interactions between the nanoclays and polymer chains. These characteristics could therefore be used to create functional hybrid hydrogels via sol-gel process, which are very suitable for minimally invasive therapies, such as injectable tissue repair matrices or bone-related tissue engineering scaffolds. In addition, due to their large specific surface area, controllable particle morphology and pore volume or interlayer space, excellent adsorption ability, ionic exchange capacity and outstanding adhesive ability, some silicon-based NPs, especially MSNs, MMT and LAP, have superb drug-carrying capability. They have been widely used to integrate into hydrogel drug delivery systems to increase drug-loading, manipulate drug pharmacological profiles, minimize drug degradation and decrease detrimental drug side effects. We summarized the advances of nanocomposite hydrogels from hydrogels and silicon-based NPs for biomedical applications. As shown in Table 2, various kinds of silicon-based NPs have been incorporated in different synthetic and natural polymers via physical or chemical approaches to obtain bioactive nanocomposite hydrogels. These resulting hydrogels with enhanced mechanical properties, good biocompatibility and biodegradability, tunable cell and tissue adhesion, or improved drug loading and drug release profiles, have exhibited plenty of important applications in biomedical and pharmaceutical fields, such as injectable or implantable sustained drug delivery system, controlled cell and tissue adhesion surfaces, antimicrobial films or wound dressings, tissue engineering and cell based therapies. For example, in our previous study, a novel organic-inorganic silica NPs-based bioadhesive hydrogel as an alternative vehicle for transdermal drug delivery system was developed. As shown in Figure 6, the direct formation of silica NPs in PVA hydrogel was observed due to the reaction between PVA and the hydrolyzed silanol of γ-(glycidyloxypropyl)trimethoxysilane (GPTMS) in the sol-gel process. The silica NPs dispersed in the matrix form hard segments in the hydrogel, which can not only significantly improve mechanical strength, skin adhesion properties and film-forming properties of PVA gels, but also can reduce the crystalline regions of PVA and hence facilitate the diffusion of drug and water vapor.

In another interesting study, Ayyub et al. developed a nanocomposite hydrogel respond to proteolytic degradation with an increase in stiffness through the formation of physical cross-links. The nanocomposite hydrogel was consisted of a colloidal array of silica NPs distributed within a PEG-peptide hydrogel, as shown in Figure 7. The negatively charged silica NPs at a sufficiently high concentration within the hydrogel can form a regular periodic structure as a photonic bandgap to reflect visible wavelengths of light. The hybrid hydrogels would collapse in response to diverse biological stimuli, causing a 1200% increase in elastic storage and loss modulus. Moreover, the material provided threshold responses, requiring a certain extent of proteolytic activity before the transition occurred. This allowed for the fabrication of Boolean logic gates responding to a specific assortment of proteases. The study demonstrated that incorporating silica NPs at a high density within a polymer hydrogel can not only result in mechanically strong and tissue-adhesive nanocomposite hydrogels, but also fabricate soft materials with a unique and counterintuitive response to environment-stimuli. The protease responsive hydrogel nanocomposites reported in this study could offer avenues in degradation-stiffening and collapsing materials for a variety of biomaterial applications.

Among various inorganic NPs, semiconductor quantum dots (QDots), such as CdTe, CdS, carbon and silicon QDots, have attracted tremendous interest due to their unique photoluminescence behavior, including high quantum yield, large absorptivity, broad absorption spectrum, improved photo-stability, concentration and size-tunable emission. These fluorescent QDots have been extensively studied and applied, such as imaging fixed and live cells all the way, high resolution localization of proteins and cellular structures, bioimaging in vivo, light-triggered drug delivery, immunoassays and innovative diagnostic methodologies. For example, cells labeled with QDots with unique photoluminescence can be injected in small animals, which can be used to follow a particular pathway in the organism, such as the carcinogenesis process. However, due to high free energy of the surface and a large surface-volume ratio, QDots tend to easily aggregate in aqueous medium, resulting in fluorescence quenching. Therefore, the dispersity and stability of QDots are extremely important for their biomedical applications, such as biosensing, bioimaging, biolabeling and drug delivery. Many techniques, especially the surface functionalization by the attachment of ionic groups, polymers, lipids and proteins, have been employed to stabilize the colloidal QDs, but these approaches suffer from the complicated synthesis steps, harsh reaction condition and tedious purification process. On the other hand, as described above, hydrogels have exhibited great potential in biomedical applications due to their unique physicochemical properties and porous network structures. In fact, hydrogels can also provide an ideal hydrated environment for the host of QDots. Moreover, the integration of fluorescent QDots into hydrogel matrix can not only provide protection to QDots against different harsh environments, but also render to the resulting composite hydrogels with unique photo-electronic properties that are highly suitable for therapeutic and diagnostic applications in biomedical fields. Fabrication of fluorescent hydrogel by incorporating QDots in the polymer hydrogel matrix has achieved promising success. For example, QDots-loaded PNIPAM nanocomposite hydrogels have been used as light-controlled drug delivery system, thermo-sensitive biochemical monitor and sensor. Generally, there are two distinct strategies for the incorporation of QDots into hydrogels, based on the covalent and noncovalent interactions between polymer chains and QDots. The former approach to QDs encapsulation involves the formation of covalent bonding, which is commonly realized by copolymerization or crosslinking of QDots carrying polymerizable ligands with proper monomers. This strategy can guarantee the firm immobilization of QDots in the hydrogel matrix. However, this approach usually involves tedious polymerization or synthetic process, and usually requires that the hydrogel polymers are able to be chemically tailored. An alternative method involves encapsulating the QDots by the diffusion of the QDots into the preformed hydrogel or the mixture of the QDots with the precursor solution of hydrogel. The entrapment processes are mainly dependent on the electrostatic interactions, hydrophobic interactions, hydrogen bonding, and host–guest interactions. These noncovalent bonding interactions, obviously, can drive the free QDots to be mostly inhaled into the hydrogels, due to the large surface area of hydrogels. However, for the case of physical embedding, the weak noncovalent interactions between the networks and the QDs may result in squeezing of the trapped QDs from the networks and a loss of luminescence. A wide variety of polymer hydrogels, such as PAM, PEG, PVA, PVP, COL and AGL, have been used to entrap QDs into the hydrogel matrices by means of the above strategies. Typically, Liu et al. combined a physical embedment and a subsequent covalent crosslinking to firmly encapsulate QDots into agarose hydrogels. Cysteamine-capped QDots can be entrapped into the pores of agarose hydrogels by hydrogen bonding between hydroxyl groups of agarose and the amino groups of cysteamine. Subsequently, oxalaldehyde and polyethylenimine were then incorporated to produce a covalently crosslinked network to further stabilize the encapsulation. In another study, Zhang et al. developed a sunlight self-initiated polymerization approach to prepare multifunctional nanocomposite hydrogels by using QDots as the initiator and introducing clay as additional non-covalent crosslinking points, as shown in Figure 8. The resulting hydrogels exhibit excellent mechanical strength and high elasticity. Moreover, the self-immobilized NPs within the functional nanocomposite gels exhibit inherent physicochemical properties, such as large absorptivity, high photoluminescence and size-tunable emission, which are comparable to those of their original solution.

3.4. Nanocomposite Hydrogels from Hydrogels and Metal NPs or Metal Oxide NPs

Hydrogels and metal or metal oxide NPs are two completely distinguished kinds of materials. Hydrogels are commonly made of natural and synthetic polymers, which possess numerous advantages over inorganic and metal materials, such as lower material cost and easier fabrication, better biocompatibility and biodegradability, and more versatile processability and functionalization. However, polymers usually display poor mechanical and thermal stability, and especially they lack some special functions, such as thermal, magnetic, optical and electrical conductivity. With the increase of popularity of hydrogels in various biomedical applications including biosensing, bioimaging and biotracking/labeling, there is a growing need to engineer hydrogels with magnetic, electrical and optical properties. Metal and metal oxide NPs possess unique characters that are not commonly found in polymer materials, which have great potential as reinforcing elements to prepare composite hydrogels with unique characteristics and tunable properties. Various types of metal and metal oxide NPs have been integrated into polymer hydrogels through a covalent or non-covalent fashion to fabricate nanocomposite hydrogels. Generally speaking, the incorporation of such NPs into hydrogel matrix by a covalent manner will lead to a relatively strong polymer-NPs interaction and thus change markedly the mechanical properties and swelling behaviors of hydrogels. On the other hand, there will be little impact on the viscoelastic and mechanical properties of the resultant hybrid hydrogels if the metallic NPs were incorporated into hydrogel networks by the weak non-covalent manner. In this case, only the properties of the NPs, such as improved magnetic, optical, electrical conductivity and enhanced antimicrobial properties are added into the hydrogels. For example, the physical entrapment of Au NPs within the HA polymeric network did not improve the mechanical properties of hydrogel, due to the presence of only the weak interactions between polymers and NPs. Nevertheless, significant increases in the stiffness were observed when surface-functionalized Au NPs can form covalent bonds to the polymer chains and crosslink with the polymeric networks.

A variety of metallic NPs, such as gold (Au), silver (Ag), platinum (Pt), cobalt (Co), nickel (Ni) and copper (Cu), and a series of metal oxide NPs including iron oxide (Fe3O4, Fe2O3), titania (TiO2), zinc oxide (ZnO), cupric oxide (CuO) as well as metal alloys and salts with desirable physicochemical properties were combined with natural and synthetic polymer networks and then were designed for diverse biomedical and pharmaceutical applications, including biological sensing, in vivo bioimaging, cell separation, drug delivery, conductive scaffolds, switchable electronics, and disease treatment. We summarized the biomedical and biological applications of nanocomposite hydrogels from hydrogels and metal or metal oxide NPs, as shown in Table 3. Due to their unique functions and relatively simple preparation process, Ag, Au and magnetic iron oxide Fe3O4 NPs are the most widely investigated class of NPs for the fabrication of functional nanocomposite hydrogels.

Recently, Ag NPs with unique optical, electronic, and antibacterial properties have attracted much attention and have found many applications in field of medicine and pharmaceutics. One of the most attractive features of Ag NPs is their remarkably strong broad-spectrum antimicrobial activity in combination with a fairly low toxicity against human tissue. However, because of strong dipole-dipole attractions between particles and high surface energy, the lack of sufficient physicochemical and dispersion stability in aqueous media limited their applications. As described above, hydrogels with large free space among the crosslinked networks can not only act as a reservoir for massive NPs loading, but also serve as a nanoreactor template for the nucleation and growth of NPs. Embedding Ag NPs in crosslinked polymer networks to obtain Ag nanocomposite hydrogels has proved to be a most promising solution for stabilization and distribution problem, due to the excellent capacity of stabilizing NPs. Normally, Ag NPs can be introduced into the matrix of polymer hydrogel by simply blending the NPs with the preformed hydrogel, entrapping NPs during the swelling process or adding the NPs during the gelation process. And Ag NPs can also be generated in situ in the swollen hydrogel, which can achieve a more uniform distribution of Ag-NPs. As described in Table 3, the incorporation of Ag NPs into hydrogels will render them with high antibacterial activity and usually change their mechanical toughness, swelling ratio and stimuli responsiveness. Hydrogels work as an efficient stabilizer of Ag NPs and control the release of the Ag NPs. More importantly, because the biocompatible hydrogels can maintain a moist environment at the wound interface, act as a barrier to microorganisms, allow sufficient air and water vapor to permeate through, and absorb or remove excess exudates, as well as attach at the target site and be easily removed without trauma and pain, Ag NPs-hydrogel composites have great potential to provide functional coatings for various applications, such as wound dressings, catheters and bone cement. It was worth pointing out that the inclusion NPs into natural polymer hydrogels, such as CS, GEL, COL and peptides can produce biodegradable composite materials, which can be employed as implantable dressings without the need of removal. In addition, Abdel-Halim et al. reported an electrically conducting nanocomposite hydrogel consisted of silver NPs and guar gum/poly(acrylic acid)hydrogel. The nanocomposite hydrogel’s electrical conductivity was found to be affected by the content of Ag NPs and the swelling ratio of the hydrogel. Endo et al. developed a surface plasmon resonance (LSPR)-based optical glucose concentration sensor by incorporation of Ag NPs into pH-responsive hydrogels. The interparticle distances of the silver NPs in the hydrogel would be increased if glucose was present on the surface of this biosensor. And thus the absorbance strength of the LSPR was decreased, which can be used to specifically determine glucose concentrations.

Similarly, the inclusion of Au NPs within the hydrogel matrix has also emerged as a promising way to form a novel class of soft nanocomposites for various applications in the biomedical fields. Au NPs with excellent optical and LSPR properties from the visible regime to the near infrared (NIR) have received intensive attention in biomedical applications. NIR light is very useful for biomedical applications because these wavelengths can penetrate deeply into biological tissues with relatively little attenuation and minimal damage, which has been wide used as a stimulus for photothermal therapy (PTT), photodynamic therapy (PDT), bioimaging and remote-controlled smart drug delivery. One of the most remarkable properties of Ag NPs is that they can effectively absorb and scatter light due to LSPR and then efficiently convert optical energy into thermal energy. Due to their very high photothermal conversion efficiency, Au NPs-hydrogel composites in combination with NIR laser irradiation have aroused tremendous interest as therapeutic agents for cancer therapy, especially for the PTT and PDT. Compared to other cancer therapies, PTT and PDT are both excellent minimally invasive therapeutic treatments. For example, Wang et al. reported a composite hydrogel that contained Au NPs, spinach extract, and PEGDA via in situ photopolymerization. Spinach extract can act as a photoinitiator to initiate the formation of the PEGDA hydrogel and serve as an excellent photosensitizer to generate cytotoxic singlet oxygen (1O2) with oxygen to kill tumor cells. Au NPs as a photoabsorbing agent can generate heat from optical energy to induce tumor tissue hyperthermia and accelerate the rate of 1O2 generation. The composite hydrogel shell on tumor cells can prevent the photosensitizer from migrating to normal tissue and keeps a high concentration on lesions, thereby enhancing the curative effect. More interestingly, a remote-controlled smart drug delivery can be easily achieved by NIR irradiating Au NPs-integrated temperature-responsive gel matrix. The gel structure will quickly collapse if the temperature rises above the lower critical solution temperature of the gel matrix due to the NIR-triggered photothermal effect. The fast response leads to an on demand burst release of drugs, which should be contributed to heat generation within the gel matrix, rather than external to the matrix. Sershen et al. firstly developed a photothermally modulated hydrogel using photoactive Au NPs in combination with thermal-responsive PNIPAM-PAM copolymers, which exhibited a controlled pulsatile release of methylene blue and proteins. As shown in Figure 9, a novel chemo-photothermal co-therapy system was developed to prevent local breast cancer recurrence. The temperature of the hybrid hydrogel system will be increased due to the photothermal effect of Au NPs under NIR irradiation, thus leading to a fast shrinkage of hydrogel and a significant increase in the release rate of loaded drug. This functional hydrogel effectively avoided breast cancer recurrence after primary tumor resection in a mouse model, due to the controlled administration of combination chemo-photothermal therapy and the decreased systemic toxicity. Besides using Au NPs based nanocomposite hydrogels for drug delivery and cancer therapy, they are also explored for biosensing, cellular therapy such as cell labeling and cell-biology research, and tissue regeneration.

Unlike those noble metals NPs, some transitional metal, such as ferreous (Fe), cobalt (Co) and nickel (Ni) based NPs, exhibit excellent magnetic properties. Among them, pure iron oxides, such as maghemite (ɣ-Fe2O3) and magnetite (Fe3O4) NPs are most common magnetic nanomaterials for biomedical applications, due to their superior biocompatibility. Moreover, the magnetic properties of these NPs can be tuned from ferromagnetic to superparamagnetic by adjusting their sizes, because of quantum size effects. As shown in Table 3, the incorporations of these magnetic NPs into polymer networks also offer a high potential for several biomedical applications, such as magnetic field induced hyperthermia, magnetic resonance imaging (MRI), drug delivery, cell tracking and protein separation. The typical biomedical applications of these magnetic hydrogel were shown in Figure 10. For example, the superparamagnetic property of iron oxide NPs can cause a temperature rise under alternating magnetic fields, and thus the use of magnetic induction hyperthermia for cancer therapy and cell-biology research has recently gained great interest. Samal et al. introduced magnetic NPs into silk fibroin protein hydrogel scaffolds via dip-coating methods. The obtained magnetic scaffolds showed excellent hyperthermia properties achieving temperature increases up to 8 °C in about 100 s, improving the cell adhesion and proliferation. Magnetic induction hyperthermia also allows the on-off response of the system depending on temperature. Liu et al. incorporated magnetic NPs into PVA matrix to create composite hydrogels, which have proven externally controlled on–off drug release from the hydrogels. The drug release behaviors can be remote-controlled by the use of a magnetic field, and the release profiles of drug were highly dependent on the particle size, strength of the magnetic field and the duration of the switching time. Composite hydrogels of thermo-sensitive PNIPAM with superparamagnetic NPs exhibited remotely-controlled thermal-responsive swelling behaviors in an alternating magnetic field. The covalent conjugation of magnetic Fe3O4 NPs and bovine serum albumin (BSA) on the hydrogels allows these materials to be applied in magnetically assisted bioseparation processes.

Several other metallic NPs, metal-oxide NPs and metal alloys NPs can also be used to integrate with polymer networks to enhance the bioactivity of hydrogels. For instance, magnetic Co or Ni NPs have also been introduced into hydrogels to form ultra-flexible and strong magnetic actuator. Some titania NPs and alumina NPs were incorporated within polymeric matrix to enhanced cell adhesion and proliferation for tissue engineering applications. However, very limited studies focused on the use of these NPs to fabricate hybrid hydrogels for biomedical applications because of their potential toxicity and rapid oxidation. Overall, various types metallic and metal-oxide colloidal particles were incorporated with polymer network structures, which can impart them with exclusive optical, electrical or magnetic properties. The resultant nanocomposite hydrogels are highly suitable for different biomedical applications, especially for diagnostic and therapeutic applications.

3.5. Nanocomposite Hydrogels from Hydrogels and Polymeric NPs or Liposomes

In comparison to conventional inorganic and low molecular weight organic materials, polymers exhibit unique properties, such as non-toxic and biocompatible nature, good physicochemical stability, excellent elasticity and ductility. Moreover, polymer chains are dynamic when polymers are conducted under usual conditions and particularly induced by an external environment, e.g., annealing, swelling and stretching, allowing for direct the self-assembly of NPs by use of polymers. Especially because of the flexibility offered by macromolecular synthesis methods, the ability to respond to specific physiological or external stimuli, the almost infinite diversity of polymers in terms of property, architecture and composition, as well as their ease of functionalization, polymers have always been the first choice for the design and development of nanomaterials with tailored physicochemical and biological properties. A wide variety of polymeric NPs, such as polymeric micelles, nanogels and particles, dendrimers as well as liposomes, have been developed and gained great attention in biomedical and pharmaceutical applications. The inclusion of these polymeric particles into a hydrogel system has been explored to improve the performance of hydrogels and polymer NPs. This strategy strongly has provided the opportunity to obtain nanocomposite hydrogels with undoubtedly improved properties and performances. The advances in the fabrication of polymer NPs and hydrogels composites and their applications in drug delivery, tissue engineering, and other biorelated domains were summarized in Table 4. In addition, some important studies in this topic were highlighted in detail and shown as below.

Polymeric NPs have obtained great attention in drug delivery applications because of their capability to entrap hydrophobic or hydrophilic drugs. Among the various polymer materials used in drug delivery and biomedical devices, poly(lactic-co-glycolic acid) (PLGA) has attracted most considerable attention because of its attractive properties, such as excellent biocompatibility and biodegradability, European Medicine Agency approval and FDA in drug delivery systems. Typically, PLGA-based polymeric NPs have been integrated into different hydrogels and the resulting nanocomposite hydrogels have shown promise to develop novel biomedical materials with useful functions. Lampe et al. entrapped PLGA microparticles within a PEG-based hydrogel to locally release two types of neurothropic factors with different release profiles. PLGA microparticles incorporated hydrogels possessing coordinated drug delivery ability can release two different neurothropic factors in different regions of the brain, significantly reducing the microglial response relative to sham surgeries, and thus providing a useful tool for further development in combining drug delivery and tissue engineering. Hydrogels have been extensively investigated as a carrier for loading and local delivery of various hydrophilic molecular cells and compounds. To tailor the release rates of multiple drugs and also manipulate the phenotypic activities of co-cultured cells in a hydrogel system, Yonet-Tanyeri et al. separately incorporated two isoforms of vascular endothelial growth factor (VEGF121 and VEGF165), into the poly(ethylene imine)-poly(ethylene glycol) diacrylate (PEI-PEGDA) gel and PLGA microparticles. And then the PEI-PEGDA gel and PLGA microparticles were embedded in the poly(ethylene glycol) dimethacrylate PEGDMA hydrogel. The PLGA microparticles were used as the VEGF165 carrier to limit initial VEGF165 burst. PEI-PEGDA gel was used as VEGF121 carrier. Apparently, a bimodal, sequential macromolecular release profile could be attained, including rapid VEGF121 release with the degradation of the PEI-PEGDA gel and sustained VEGF165 release from the PLGA microparticles. A novel polymer coating consisting of PLGA microspheres dispersed in PVA hydrogels was developed in combination with dummy sensors as a “smart” drug eluting coating with high biocompatibility for implantable biosensors to avoid the foreign body response, and thus improve sensor performance in vivo. The polymeric microspheres slowly release tissue-modifying drugs at the implantation sites to control the inflammation and fibrous encapsulation, while the hydrogel allows rapid analyte diffusion to the sensing elements. Samanta et al. reported a generalized pH-sensitive drug delivery system based on polypyrrole nanoparticles (PPy NPs) with good drug loading capacity, which can be immobilized in a calcium alginate hydrogel, allowing for sustained release of the incorporated drug for more than 21 days. Luo et al. synthesized a kind of NIR laser responsive material from agarose/alginate double network hydrogels composited with PPy NPs. As shown in Figure 11, the combination of alginate and agarose was synergistic. The agarose/PPy network provides the hydrogel with capability of responding to light. On the other hand, non-thermal-responsive alginate keeps the mechanical properties of the hydrogel during irradiation. Moreover the agarose hydrogel network was able to form a supporting template for Ca2+ diffusion control, which regulated alginate gelation processes and forms objects with shapes. As a result, the hybrid hydrogel exhibited pulsatile releasing behaviors according to the laser switching while maintaining its morphology and mechanical strength.

Wang et al. reported an advanced hybrid hydrogel that integrates toxin nanosponges (red blood cell (RBC) membrane-coated PLGA nanoparticle system) with PAM hydrogel for local treatment of bacterial infection, as shown in Figure 12. The hydrogel can effectively withhold the nanosponges in its matrix without compromising toxin transport for neutralization. After subcutaneous injection to mice, the hybrid hydrogel can also effectively anchor the nanosponges at the injection sites (a property facilitating toxin absorption), showing significant antivirulence therapeutic efficacy. This study demonstrated the incorporation of the nanosponges into hydrogel provide a new and effective detoxification strategy for the treatment of localized bacterial infection. In addition of PLGA particles, a wide variety of polymeric NPs or microparticles have been used to combine with hydrogel system to form nanocomposite hydrogels with unique physicochemical and biological properties, as shown in Table 4. These approaches have provided a promising novel platform for drug delivery and tissue engineering, especially for sustained delivery of multiple drugs at respective rate.

Polymer micelles are a typical type of nanoscale polymeric particles, which are generated from self-assembly of amphiphilic block-copolymers in water. They present a core-shell structure wherein the hydrophilic corona imparts colloidal stability against aggregation while the hydrophobic core can serve as a microenvironment for the incorporation of drugs. Due to their abundant chemical diversity, functionality and tunable physicochemical properties, micelles are one of the most versatile nanocarriers for the delivery of hydrophobic drugs. The incorporation of the nanosized micelles into hydrogels provides not only a multiple drug delivery system, but also an excellent means to tune physical properties of the hydrogels. Jin et al. developed pH-responsive block copolymer micelles as drug carriers for use in hydrogel scaffolds for neural repair, as shown in Figure 13. These micelles are formed from PEG-b-poly(2-(N,N-diisopropylamino)ethyl methacrylate) (PEG-b-PDPAEMA) with pH sensitivity due to the tertiary amine groups of PDPAEMA. The incorporation of these micelles into agarose hydrogels to obtain hybrid hydrogels with capable of stimulus-triggered drug release, which could allow the controlled delivery of hydrophobic neuroprotective agents to improve survival of transplanted cells in tune with signals from the surrounding pathological environment. Micelles have also been incorporated into hydrogels to enhance their mechanical properties. Xiao and coworkers covalently incorporated polymer self-assembled micelles into PAM hydrogel. The mechanical properties of the micelle-linked PAM hydrogel can be regulated by adjusting the amount of micelles. 4-fold increase in Young’s modulus and 2-fold increase in tensile stress were observed when the concentration of micelles was increased from 7.5 to 15 mg/mL.

Liposomes are a kind of micelles from the self-assembly of phospholipids dispersed in an aqueous environment. These vesicles contain an aqueous volume entirely enclosed by a lipid bilayer membrane. Manipulation of composition, size, charge and lamellarity of liposomes allow the entrapment of payload both in the aqueous compartment and within the membrane. Hydrogels embedded with liposomes may generate a drug delivery system with desirable features and superior performance. Weiner et al. may be the first to introduce liposomes into collagen gel. They observed that the release rate of payloads encapsulated in liposomes decreased in the presence of the hydrogel. The use of liposomes for drug incorporation within the matrix of hydrogel contact lenses is especially promising due to their thermodynamic stability and high drug-loading capacity. Especially, this kind of nanocomposite hydrogels enables the possibility of achieving a controlled and sustained drug release in the eye without compromising the optical performance. In other words, this strategy can avoid the major limitation of common dosage (eye drops), which is the extremely short residence time of drug in the cornea because of the rapid clearance and the dilutive effect of tears. Gulsen et al. encapsulated various drugs in liposomes consisting of dimyristoyl phosphatidylcholine (DMPC) followed by incorporation into the hydrogel contact lenses. It was found that these hydrogel can control drug release for up to 8 days. Wickremasinghe et al. created a unique nanocomposite hydrogel by stepwise self-assembly of liposomes and multidomain peptide fibers, as shown in Figure 14A. The two-component system can achieve controlled release of desired growth factors and cytokines over multiple time scale. This bimodal release system would have great potential in the field of tissue engineering and regenerative medicine.

Polymer vesicles, usually called polymersomes, are sphere-like shell structures in which an aqueous compartment is enclosed by a bilayer membrane generatedfrom the self-assembly of amphiphilic block copolymers. In comparison with liposomes, polymer vesicles possessing better stability, higher toughness, tailorable membrane properties are attractive candidates for applications including drug delivery, encapsulation and nanoreactors. Polymeric vesicles have also been embedded in hydrogel to prepare functional nanocomposite hydrogels. For example, Litvinchuk et al. reported a long-term stability of poly(2-methyl oxazoline-block-polydimethylsiloxane-block poly(2-methyl oxazoline) (PMOXA-PDMS-PMOXA) vesicles loaded in PVA hydrogels. The study found that the vesicles in the hydrogel are stable and the drugs could diffuse quickly throughout the PVA hydrogel, providing a promising controlled release system for water soluble drugs. Hao et al. developed a thermal-responsive self-healing nanocomposite hydrogel by mixing hydrophobically modified chitosan with vesicle solution. This vesicle-based nanocomposite hydrogel exhibited an interesting self-healing feature in a matter of seconds through the autonomic reconstruction without the use of healing agent. Mart et al. reported a new type of tissue-mimetic material, magnetically-sensitive vesicle-embedded composite ALG hydrogels. These vesicle gels contain vesicles crosslinked by Fe3O4 magnetic nanoparticles, as shown in Figure 14B. And these magnetic nanoparticle–vesicle assemblies render the prepared hydrogels the ability of hosting membrane-bound enzymes/glycolipids and responding to alternating magnetic fields to reach a magnetic trigger-controlled release of stored drugs or bio(macro)molecules, leading to potential applications as smart scaffolds for stem cells or remotely triggered in vivo drug delivery systems.

Typically, nanogel, a nanosized crosslinked polymer network, is an ideal nanocarrier for biomacromolecular drugs, as it can be effective in minimizing protein-denaturation by trapping the protein drug in a hydrated microenvironment. In one study, protein-loaded nanogels were physically encapsulated into a hyaluronan (HYA) hydrogel system for sustained delivery of protein. The proteins were spontaneously trapped into the nanocomposite hydrogel without any obvious denaturation by the physical entrapment of nanogels in the HYA gel. The long-term release of protein both in vitro and in vivo was achieved by controlling the density of the HYA gel. This study offered a biocompatible, safe and sustained release formulation for proteins without the problem of denaturation of proteins in the formulation and during the formulation process. Park et al. reported a hybrid hydrogel system composed of an in situ cross-linkable gelatin-poly(ethylene glycol)-tyramine (GPT) hydrogel and a self-assembled heparin-pluronic (HP) nanogel. As shown in Figure 14C, the hybrid hydrogels were prepared via enzymatic reaction in the presence of horseradish peroxidase and hydrogen peroxide. The injectable GPT hydrogels can play a role as a physical bulking reagent and the growth factor (GF)-loaded HP nanogels allow sustained release of GFs from the matrix to improve urethral tissue regeneration. The results indicated that the hybrid gel matrix can release GF continuously up to 28 days and stimulate the regeneration of the urethral muscle tissue around the urethral wall, which may offer an advanced therapeutic method for treating the urinary incontinence as well as an application for regenerative medicine.

Among the various types of polymeric NPs, dendrimer, a synthetic polymeric macromolecule of nanometer dimensions, are particularly fascinating, due to its unparalleled molecular uniformity, narrow molecular weight distribution, defined size and shape characteristics, highly branched structure, available internal cavity as well as a multifunctional terminal surface. These physicochemical characteristics of dendrimers, especially the multitude of functional groups on their periphery and abundant cavities within their interior, lead to higher reactivity and loading efficiency compared to the linear polymers, which make these macromolecules appropriate candidates for drug delivery. Dendritic nanoparticles can also be incorporated into the hydrogel network via covalent or non-covalent interactions between dendrimers and the polymeric chains to obtain reinforced nanocomposite hydrogels with specific performance. For example, Desai et al. developed a photocurable PEG hydrogel crosslinked with polyamidoamine (PAMAM) dendrimers, and the cytocompatibility, swelling and degradation of the resulting nanocomposite hydrogels can be controlled by modification of the chain length and charge density of PAMAM dendrimers. In another study, PAMAM NPs were physically integrated within COL scaffolds to improve the mechanical stiffness and structural integrity. Interestingly, the human conjunctival fibroblast proliferation in COL hydrogels was significantly improved due to that the addition of PAMAM NPs can increase the stiffness of nanocomposite network. The use of these dendrimers-based nanocomposite hydrogels are envisioned in biomedical and pharmaceutical fields that require porous structure with controlled drug release properties. Söntjens et al. reported a novel hydrogel scaffold for cartilage repair, based on a water-soluble and multivalent triblock copolymer consisting of methacrylated poly(glycerol succinic acid) dendrimer terminal blocks and a poly(ethylene glycol) core. The terminal methacrylates allow biocompatible and mild photo-crosslinking with a visible light, which will facilitate in vivo filling of irregularly shaped defects with the dendrimer-based scaffold. The multivalent dendrimer components allow high crosslink densities, which will inhibit the swelling after crosslinking and simultaneously introduce biodegradation sites. The degradation properties, mechanical properties and water content of the hydrogel can easily be tailored by changing the biodendrimer concentration. Zhang et al. reported a photocrosslinkable hyperbranched polyesters (HEP)-based hydrogel with sustained drug release profiles for cellular therapies. These photocrosslinkable HPE not only can encapsulate hydrophobic drug molecules in the HPE cavities, but also can form hybrid hydrogels with a mechanically tough network and a highly porous interconnected structure upon UV exposure. The physical properties of the resulting hydrogels, such as the microstructure, compressive modulus and drug retainability, as well as cell adhesion and proliferation can be tunable by changing the crosslinking density. The nanocomposite hydrogel showed a spatial control of cell adhesion and controlled release of hydrophobic drug, which is difficult to achieve when using conventional hydrogels made from linear polymers. Wang et al. reported a PAMAM dendrimer-based poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) hydrogel with a highly porous structure. In comparison with hydrogel without incorporating dendrimer, the nanocomposite hydrogels exhibit reduced swelling, enhanced mechanical stiffness, and better cell adhesion, differentiation, and proliferation. These studies indicated that the hyperbranched dendrimers can be used to reinforce polymeric network and impart hydrogels a stable attachment and a high binding capacity to proteins and drugs. The nanocomposite hydrogels from dendrimers NPs with tailored physicochemical properties exhibited a promising potential to serve as a model for developing advanced materials for various tissue engineering and drug delivery applications.

Overall, the fabrication of composite materials by integrating polymer NPs into hydrogels can not only surmount individual shortcomings, but also generate newborn characters. The hydrogels can preserve the structural integrity and the functionalities of the contained NPs and anchor the NPs at the target site. Meanwhile, NPs entrapped into hydrogel allow a more flexible loading and controlled release of drugs. Apparently, due to the synergistic benefits, mechanically stiff hydrogels with controlled drug delivery characteristics will provide an efficient route to improve the performances and expand application scopes of hydrogels and NPs. However, it was worth pointing out that additional animal experiments are required to examine their behavior in vivo, as most of the studies on polymer NPs-based hybrid hydrogels have been performed in vitro.

4. Conclusions and Future Perspective

During the past several decades, hydrogels and nanoparticles have already exerted a dramatic impact in biological, biomedical, pharmaceutical and diagnostic fields. However, their some intrinsic shortcomings severely restrict their practical applications. Significant efforts have been paid to improve the performance of hydrogels and NPs. The fabrication of composite materials by combining two or more components in a single entity can surmount individual shortcomings and give rise to synergistic functions that are absent in the individual components. The incorporation of NPs in three-dimensional polymeric hydrogel matrix as an innovative means to obtain nanocomposite hydrogels with improved properties and multiple functionalities has gained enormous attention in many areas. On the basis of this review, we can found that various types of NPs, such as carbon-based NPs, silicon-based NPs, metal NPs and polymeric NPs are combined with the polymeric hydrogel network to create multicomponent systems. The porous structure and free space within the hydrogel networks can not only provide an ideal hydrated environment for the stabilization of NPs without aggregations or disintegration and the protection of NPs from degradation or denaturation, but also work as a reservoir to localize NPs at the target site. More importantly, the coatings of hydrogels around the NPs endow a hydration layer, which often is an essential prerequisite for the biomedical and biological applications of inorganic and metal NPs, as the hydration layer can significantly improve the biocompatibility and reduce the cytotoxicity. On the other hand, the incorporation of NPs into hydrogels can not only markedly improve their mechanical, elastic and adhesive properties as well as physicochemical and thermal stability, but also promote the cell attachment and proliferation and improve drug loading capacity and drug release profiles. More significantly, the encapsulation of carbon, metal colloidal particles or quantum dots into polymer hydrogel networks will impart them with exclusive thermal, sonic, optical, electrical or magnetic properties, which are not achieved by individual polymeric systems and are highly appropriate for various applications, especially for therapeutic and diagnostic applications. Apparently, the benefits of the combination of NPs and hydrogels have resulted in generation of a new class of advanced materials with unique properties that have a wide spectral range of biomedical applications, ranging from controlled drug delivery depots, cell and tissue adhesive matrices, wound dressing and tissue engineering scaffolds, stem cell engineering and regenerative medicines, biosensors, actuators and other biomedical devices.

However, despite of the vast potential applications of nanocomposite hydrogels in biomedical fields, there are still lots of challenges to be overcome before they can be applied in clinical use. For example, the improved performance of the nanocomposite hydrogels is mainly ascribed to the enhanced interactions between the NPs and polymer chains. Therefore, apart from particle parameters (size, shape, surface properties of NPs), the quantity and homogeneity of NPs integration are still a matter of concern. To obtain excellent performance, NPs should be abundantly and homogeneously dispersed within the hydrogel matrix. However, due to a large surface area, hydrophobic NPs physically embedded in the hydrophilic polymer matrix often tend to aggregate, leading to the failure of anticipative enhancement of properties. Therefore, there is still a need to elucidate the mechanisms and interactions between NPs and polymer chains inside the nanocomposite hydrogels, and the simple, cost-effective, scalable and reproducible preparations of nanocomposite hydrogels with desirable properties need to be investigated thoroughly. Apparently, the nanocomposite hydrogels combining the individual functions of NPs and hydrogels are ideal candidates for multimodal drug delivery platform with simultaneous capabilities in drug encapsulation, targeting delivery, photothermal therapy and in vivo imaging. This synergistic performance is usually not be achieved by an individual. However, the more detailed pharmacological studies need to demonstrate the therapeutic efficacy and biological responses. In addition, most of nanocomposite hydrogels have been performed only in vitro. Therefore, in future studies, the detailed performances (gelation time, swelling, elastic modulus, responsivity and functionality), long-term toxicity and biodegradability as well as the biological properties such as protein adsorption, cell adhesion, tissue compatibility and whole-body effect of such hydrogels under in vivo conditions should be clearly addressed. In summary, there should be a coordinated and comprehensive research to establish fundamental interactions among nanoparticulate materials, hydrogel matrices and biological systems, before hydrogels will become practical and useful in this exciting field. All these challenges will drive the effective collaboration of scientists from the fields of chemistry, materials, engineering, biology, medicine and nanoscience. We look forward to seeing many exciting research accomplishments in this burgeoning field of bio-related nanocomposite hydrogels.

References 457

  1. 1.

    Hoare T.R., Kohane D.S. Hydrogels in drug delivery: Progress and challenges. Polymer. 2008;49:1993-2007.

    Not in our library10.1016/j.polymer.2008.01.027

  2. 2.

    Li Y., Rodrigues J., Tomas H. Injectable and biodegradable hydrogels: Gelation, biodegradation and biomedical applications. Chem. Soc. Rev. 2012;41:2193-2221.

    Not in our library10.1039/c1cs15203c

  3. 3.

    Annabi N., Tamayol A., Uquillas J.A., Akbari M., Bertassoni L.E., Cha C., Camci-Unal G., Dokmeci M.R., Peppas N.A., Khademhosseini A. 25th Anniversary article: Rational design and applications of hydrogels in regenerative medicine. Adv. Mater. 2014;26:85-124.

    Not in our library10.1002/adma.201303233

  4. 4.

    Caló E., Khutoryanskiy V.V. Biomedical applications of hydrogels: A review of patents and commercial products. Eur. Polym. J. 2015;65:252-267.

    Not in our library10.1016/j.eurpolymj.2014.11.024

  5. 5.

    Seliktar D. Designing cell-compatible hydrogels for biomedical applications. Science. 2012;336:1124-1128.

    Not in our library10.1126/science.1214804

  6. 6.

    Hoffman A.S. Hydrogels for biomedical applications. Adv. Drug Deliv. Rev. 2012;64:18-23.

    Not in our library10.1016/j.addr.2012.09.010

  7. 7.

    Peppas N.A., Hilt J.Z., Khademhosseini A., Langer R. Hydrogels in biology and medicine: From molecular principles to bionanotechnology. Adv. Mater. 2006;18:1345-1360.

    Not in our library10.1002/adma.200501612

  8. 8.

    Slaughter B.V., Khurshid S.S., Fisher O.Z., Khademhosseini A., Peppas N.A. Hydrogels in regenerative medicine. Adv. Mater. 2009;21:3307-3329.

    Not in our library10.1002/adma.200802106

  9. 9.

    Miyata T., Uragami T., Nakamae K. Biomolecule-sensitive hydrogels. Adv. Drug Deliv. Rev. 2002;54:79-98.

    Not in our library10.1016/s0169-409x(01)00241-1

  10. 10.

    Qiu Y., Park K. Environment-sensitive hydrogels for drug delivery. Adv. Drug Deliv. Rev. 2012;64:49-60.

    Not in our library10.1016/j.addr.2012.09.024

  11. 11.

    Hoffman A.S. Stimuli-responsive polymers: Biomedical applications and challenges for clinical translation. Adv. Drug Deliv. Rev. 2013;65:10-16.

    Not in our library10.1016/j.addr.2012.11.004

  12. 12.

    Ward M.A., Georgiou T.K. Thermoresponsive polymers for biomedical applications. Polymers. 2011;3:1215-1242.

    Not in our library10.3390/polym3031215

  13. 13.

    Wichterle O., Lim D. Hydrophilic gels for biological use. Nature. 1960;185:117-118.

    Not in our library10.1038/185117a0

  14. 14.

    Zhu J.M. Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering. Biomaterials. 2010;31:4639-4656.

    Not in our library10.1016/j.biomaterials.2010.02.044

  15. 15.

    Lin C.-C. Recent advances in crosslinking chemistry of biomimetic poly(ethylene glycol) hydrogels. RSC Adv. 2015;5:39844-39853.

    Not in our library10.1039/c5ra05734e

  16. 16.

    Maitra J., Shukla V.K. Cross-linking in Hydrogels—A Review. Am. J. Polym. Sci. 2014;4:25-31.

    Not in our library

  17. 17.

    Ebara M., Kotsuchibashi Y., Narain R., Idota N., Kim Y.-J., Hoffman J.M., Uto K., Aoyagi T., Ebara M., Kotsuchibashi Y., Narain R., Idota N., Kim Y.J., Hoffman J.M., Uto K., Aoyagi T. Smart Hydrogels. Smart Biomaterials. 2014;9-65.

    Not in our library

  18. 18.

    Huang P., Wang W., Zhou J., Zhao F., Zhang Y., Liu J., Liu J., Dong A., Kong D., Zhang J. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery. ACS Appl. Mater. Interfaces. 2015;7:6340-6350.

    Not in our library10.1021/acsami.5b00962

  19. 19.

    Zhang J., Lin X., Liu J., Zhao J., Dong H., Deng L., Liu J., Dong A. Sequential thermo-induced self-gelation and acid-triggered self-release process of drug-conjugated nanoparticles: A strategy for sustained and controlled drug delivery to tumor. J. Mater. Chem. B. 2013;1:4667-4677.

    Not in our library10.1039/c3tb20597e

  20. 20.

    Thomas V., Namdeo M., Mohan Y.M., Bajpai S.K., Bajpai M. Review on polymer, hydrogel and microgel metal nanocomposites: A facile nanotechnological approach. J. Macromol. Sci. Pure Appl. Chem. 2008;45:107-119.

    Not in our library10.1080/10601320701683470

  21. 21.

    Hu Z., Chen G. Novel nanocomposite hydrogels consisting of layered double hydroxide with ultrahigh tensibility and hierarchical porous structure at low inorganic content. Adv. Mater. 2014;26:5950-5956.

    Not in our library10.1002/adma.201400179

  22. 22.

    Merino S., Martin C., Kostarelos K., Prato M., Vazquez E. Nanocomposite Hydrogels: 3D Polymer-Nanoparticle Synergies for On-Demand Drug Delivery. ACS Nano. 2015;9:4686-4697.

    Not in our library10.1021/acsnano.5b01433

  23. 23.

    Bonanno L.M., Segal E. Nanostructured porous silicon-polymer-based hybrids: From biosensing to drug delivery. Nanomedicine. 2011;6:1755-1770.

    Not in our library10.2217/nnm.11.153

  24. 24.

    Ye E., Loh X.J. Polymeric Hydrogels and Nanoparticles: A Merging and Emerging Field. Aust. J. Chem. 2013;66:997-1007.

    Not in our library10.1071/ch13168

  25. 25.

    Gaharwar A.K., Peppas N.A., Khademhosseini A. Nanocomposite hydrogels for biomedical applications. Biotechnol. Bioeng. 2014;111:441-453.

    Not in our library10.1002/bit.25160

  26. 26.

    Xu S., Deng L., Zhang J., Yin L., Dong A. Composites of electrospun-fibers and hydrogels: A potential solution to current challenges in biological and biomedical field. J. Biomed. Mater. Res. B. 2015.

    Not in our library10.1002/jbm.b.33420

  27. 27.
  28. 28.

    De M., Ghosh P.S., Rotello V.M. Applications of Nanoparticles in Biology. Adv. Mater. 2008;20:4225-4241.

    Not in our library10.1002/adma.200703183

  29. 29.

    Thanh N.T.K., Green L.A.W. Functionalisation of nanoparticles for biomedical applications. Nano Today. 2010;5:213-230.

    Not in our library10.1016/j.nantod.2010.05.003

  30. 30.

    Kim T., Hyeon T. Applications of inorganic nanoparticles as therapeutic agents. Nanotechnology. 2014;25.

    Not in our library10.1088/0957-4484/25/1/012001

  31. 31.

    Doane T.L., Burda C. The unique role of nanoparticles in nanomedicine: Imaging, drug delivery and therapy. Chem. Soc. Rev. 2012;41:2885-2911.

    Not in our library10.1039/c2cs15260f

  32. 32.

    Nicolas J., Mura S., Brambilla D., Mackiewicz N., Couvreur P. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chem. Soc. Rev. 2013;42:1147-1235.

    Not in our library10.1039/c2cs35265f

  33. 33.

    Arvizo R.R., Bhattacharyya S., Kudgus R.A., Giri K., Bhattacharya R., Mukherjee P. Intrinsic therapeutic applications of noble metal nanoparticles: Past, present and future. Chem. Soc. Rev. 2012;41:2943-2970.

    Not in our library10.1039/c2cs15355f

  34. 34.

    Elsabahy M., Wooley K.L. Design of polymeric nanoparticles for biomedical delivery applications. Chem. Soc. Rev. 2012;41:2545-2561.

    Not in our library10.1039/c2cs15327k

  35. 35.

    Hong H., Chen F., Cai W. Pharmacokinetic issues of imaging with nanoparticles: Focusing on carbon nanotubes and quantum dots. Mol. Imaging Biol. 2013;15:507-520.

    Not in our library10.1007/s11307-013-0648-5

  36. 36.

    Chung C., Kim Y.K., Shin D., Ryoo S.R., Hong B.H., Min D.H. Biomedical applications of graphene and graphene oxide. Acc. Chem. Res. 2013;46:2211-2224.

    Not in our library10.1021/ar300159f

  37. 37.

    Li Z., Barnes J.C., Bosoy A., Stoddart J.F., Zink J.I. Mesoporous silica nanoparticles in biomedical applications. Chem. Soc. Rev. 2012;41:2590-2605.

    Not in our library10.1039/c1cs15246g

  38. 38.

    Bitar A., Ahmad N.M., Fessi H., Elaissari A. Silica-based nanoparticles for biomedical applications. Drug Discov. Today. 2012;17:1147-1154.

    Not in our library10.1016/j.drudis.2012.06.014

  39. 39.

    Soenen S.J., Parak W.J., Rejman J., Manshian B. (Intra)cellular stability of inorganic nanoparticles: Effects on cytotoxicity, particle functionality, and biomedical applications. Chem. Rev. 2015;115:2109-2135.

    Not in our library10.1021/cr400714j

  40. 40.

    Dou Q.Q., Guo H.C., Ye E. Near-infrared upconversion nanoparticles for bio-applications. Mater. Sci. Eng. C. 2014;45:635-643.

    Not in our library10.1016/j.msec.2014.03.056

All 457 references

Cited by papers we hold 3

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.